STAT3 and Familial prostate cancer: The anti-cancer properties of lutein (3,4,2′,4′-tetrahydroxychalcone) against various carcinomas involve the suppression of STAT3 activation in head and neck cancer, liver cancer, malignant pleural mesothelioma, myeloma, and prostate cancer [26,27].